Meningitis Encephalitis: a Metagenomics-Based Etiology & Epidemiology Research

NCT04724876 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-01-26

No results posted yet for this study

Summary

Autoimmune encephalitis (AE) is caused by abnormal immune response mediated by autoimmune antibodies of patients, which can be detected by a serial of autoimmune antibodies\[4,5,6,7\]. At present, the traditional infection diagnosis mainly relies on microbial culture method, which has the characteristics of long cycle, high cost, low detection rate and complex detection process. About 30-60% of encephalitis have unknown etiology\[2,3\]. On the other hand, the diagnosis and classification of noninfectious encephalitis mainly depend on the detection of autoimmune antibodies, the scope of diagnosis and differential diagnosis is limited, and the relationship between autoimmune encephalitis and infection factors is still unclear. Metagenomics sequencing (mNGS) is a new method that does not rely on microbial culture and can directly detect pathogenic nucleic acids. It has the characteristics of fast, accurate, high throughput, no preference for different pathogen detection, and can detect known and unknown pathogens at the same time. Nowadays, mNGS is widely used in the field of pathogen detection.

Conditions

  • Central Nervous System Infections and Inflammations

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER
  • Air Force Military Medical University, China

    collaborator OTHER
  • Peking Union Medical College Hospital

    collaborator OTHER
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • Xuanwu Hospital, Beijing

    collaborator OTHER
  • Third Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Fudan University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Central South University

    collaborator OTHER
  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER
  • Beijing Tongren Hospital

    lead OTHER

Principal Investigators

  • Jiawei Wang, Doctor · Beijing Tong Ren Hospital

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04724876 on ClinicalTrials.gov